Literature DB >> 1809690

Induction of mediator release from human glomerular mesangial cells by the terminal complement components C5b-9.

M Schönermark1, R Deppisch, G Riedasch, K Rother, G M Hänsch.   

Abstract

Exposure of cultured human glomerular mesangial cells (GMC) to normal human serum and an activator of the complement system results in rapid uptake of the terminal complement proteins C5b-9 by the cells. This 'innocent bystander' complement attack, however, does not result in cell killing, but in the stimulation of the GMC to release prostaglandin E (PGE), interleukin 1 (Il-1) and tumor necrosis factor (TNF). Endogenously synthesized Il-1 in turn activates PGE release, indicating that the C5b-9 attack initiates an autocrine feedback stimulation. Together with the fact that C5b-9 is found in many forms of glomerulonephritis, the data point to a role of the terminal complement proteins in the initiation and perpetuation of an inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1809690     DOI: 10.1159/000235517

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  12 in total

Review 1.  Mechanisms of immune-deposit formation and the mediation of immune renal injury.

Authors:  Masaomi Nangaku; William G Couser
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

2.  Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation.

Authors:  K S Kilgore; E Schmid; T P Shanley; C M Flory; V Maheswari; N L Tramontini; H Cohen; P A Ward; H P Friedl; J S Warren
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

3.  N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus.

Authors:  Tang-Dong Liao; Pablo Nakagawa; Branislava Janic; Martin D'Ambrosio; Morel E Worou; Edward L Peterson; Nour-Eddine Rhaleb; Xiao-Ping Yang; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2015-03-04

4.  Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells.

Authors:  P G Conaldi; L Biancone; A Bottelli; A De Martino; G Camussi; A Toniolo
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.

Authors:  Fei Qiao; Carl Atkinson; Mark S Kindy; Anandakumar Shunmugavel; B Paul Morgan; Hongbin Song; Stephen Tomlinson
Journal:  Am J Pathol       Date:  2010-10-15       Impact factor: 4.307

6.  The membrane attack complex (C5b-9) in liver cold ischemia and reperfusion injury.

Authors:  Constantino Fondevila; Xiu-Da Shen; Seiichiro Tsuchihashi; Yoichiro Uchida; Maria Cecilia Freitas; Bibo Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2008-08       Impact factor: 5.799

7.  Modulation of leukocyte recruitment and IL-8 expression by the membrane attack complex of complement (C5b-9) in a rabbit model of antigen-induced arthritis.

Authors:  Nicole L Tramontini; Paul J Kuipers; Colleen M Huber; Kerri Murphy; Keith B Naylor; Autumn J Broady; Kenneth S Kilgore
Journal:  Inflammation       Date:  2002-12       Impact factor: 4.092

8.  C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells.

Authors:  S Sacks; W Zhou; R D Campbell; J Martin
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

9.  Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy.

Authors:  T J Neale; B M Rüger; H Macaulay; P R Dunbar; Q Hasan; A Bourke; R P Murray-McIntosh; A R Kitching
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

10.  CD59a deficiency exacerbates ischemia-reperfusion injury in mice.

Authors:  Daniel Turnberg; Marina Botto; Margarita Lewis; Wuding Zhou; Steven H Sacks; B Paul Morgan; Mark J Walport; H Terence Cook
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.